Whale Analyzer
Patient Capital Management 13F Holdings and Portfolio Changes
Patient Capital Management reported $3.05B in 13F securities for Q2 2026, with 40 positions. Values are as of the report date; option positions, when present, use underlying-security values. This is not complete fund assets or investment performance.
Open interactive portfolioLatest 13F portfolio changes
New or increased positions include UNITEDHEALTH GROUP (UNH), Amazon (AMZN), NORWEGIAN CRUISE LINE HLDGS (NCLH), and QXO. Reduced or exited positions include ROYALTY PHARMA (RPRX), CITIGROUP (C), Alphabet (GOOGL), and NVIDIA (NVDA). These are comparisons between reported positions, not a record of execution dates, prices or cash traded.
Latest filing metadata: quarter Q2 2026; report date 2026-06-30; filing date 2026-08-13; disclosure source SEC 13F.
Reported holdings and concentration
Patient Capital Management's Q2 2026 13F report contains 40 positions valued at $3.05B. The largest reported holdings include ROYALTY PHARMA, CITIGROUP, Alphabet, UNITEDHEALTH GROUP, and Amazon.
The three largest positions in the holdings table account for approximately 19.5% of reported 13F value. The largest reported sector exposure is Other at 24.4% of the disclosed portfolio.
The filing metadata lists report date 2026-06-30, filing date 2026-08-13, SEC accession 0001854794-26-000005. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.
Patient Capital Management portfolio analytics
the top five positions account for 30.9% of disclosed value; the largest sector exposure is Health Care at 19.8%.
Top reported holdings
| Holding | Reported value | Weight | Quarter change |
|---|---|---|---|
| RPRX whale holders ROYALTY PHARMA PLC | $201.8M | 6.7% | Reduced |
| C whale holders CITIGROUP INC | $196.4M | 6.5% | Reduced |
| GOOGL whale holders ALPHABET INC | $187.9M | 6.2% | Reduced |
| UNH whale holders UNITEDHEALTH GROUP INC | $182.0M | 6.0% | Increased |
| AMZN whale holders AMAZON COM INC | $162.3M | 5.4% | Increased |
| NVDA whale holders NVIDIA CORPORATION | $142.0M | 4.7% | Reduced |
| CVS whale holders CVS HEALTH CORP | $127.8M | 4.2% | Reduced |
| NCLH whale holders NORWEGIAN CRUISE LINE HLDGS | $127.3M | 4.2% | Increased |
| QXO whale holders QXO INC | $123.3M | 4.1% | Increased |
| ET whale holders ENERGY TRANSFER L P | $116.3M | 3.9% | Reduced |
New and increased positions
Largest reported position values among additions; not amounts spent buying.
- UNH whale holders — UNITEDHEALTH GROUP INC ($182.0M)
- AMZN whale holders — AMAZON COM INC ($162.3M)
- NCLH whale holders — NORWEGIAN CRUISE LINE HLDGS ($127.3M)
- QXO whale holders — QXO INC ($123.3M)
- PGEN whale holders — PRECIGEN INC ($108.5M)
- CHYM whale holders — CHIME FINL INC ($83.6M)
Reduced and exited positions
Sorted by reported position value; exits use the prior report. These are not sale proceeds.
- RPRX whale holders — ROYALTY PHARMA PLC ($201.8M)
- C whale holders — CITIGROUP INC ($196.4M)
- GOOGL whale holders — ALPHABET INC ($187.9M)
- NVDA whale holders — NVIDIA CORPORATION ($142.0M)
- CVS whale holders — CVS HEALTH CORP ($127.8M)
- ET whale holders — ENERGY TRANSFER L P ($116.3M)
Allocation
- Other: 24.4%
- Health Care: 19.8%
- Consumer Discretionary: 15.5%
- Financials: 11.6%
- Communication Services: 9.4%
- Information Technology: 8.7%
- Industrials: 4.7%
- Energy: 3.9%
Data notes
Report date: 2026-06-30
Disclosure source: SEC 13F
Read the original SEC filing (0001854794-26-000005)
SEC 13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.
Related investor portfolios
Profiles with the same disclosure type, ordered by overlap among their top 20 reported holdings.
- Davis Advisors 13F holdings and portfolio changes — Davis Advisors
- Dodge & Cox 13F holdings and portfolio changes — Dodge & Cox
- Soros Fund Management 13F holdings and portfolio changes — Soros Fund Management
- Altimeter Capital 13F holdings and portfolio changes — Altimeter Capital
- Atreides Management 13F holdings and portfolio changes — Atreides Management
- Capital Research Global Investors 13F holdings and portfolio changes — Capital Research Global Investors
- Coatue Management 13F holdings and portfolio changes — Coatue Management
- First Pacific Advisors 13F holdings and portfolio changes — First Pacific Advisors
Learn more in Whale Analyzer Academy
Learn more in Whale Analyzer Academy:
Questions about this 13F filing
What does Patient Capital Management report for Q2 2026?
The filing reports 40 positions and $3.05B in 13F securities. The holdings table shows reported values and weights; option values follow the filing's reporting conventions.
What changed between filings?
New or increased positions include UNITEDHEALTH GROUP (UNH), Amazon (AMZN), NORWEGIAN CRUISE LINE HLDGS (NCLH), and QXO. Reduced or exited positions include ROYALTY PHARMA (RPRX), CITIGROUP (C), Alphabet (GOOGL), and NVIDIA (NVDA).
Do these amounts show how much was bought or sold?
No. The change lists are ranked by reported position value. Exited positions use their value in the prior report. These amounts are not execution prices, cash invested or sale proceeds.
Is this the current portfolio?
No. Form 13F is a quarter-end snapshot, generally filed within 45 days of quarter end. It excludes short positions and does not cover every asset. Compare the report date and filing date before using the data.